TCRGOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Cannaisseur Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.06+0.06 (+1233.33%)
Close on Aug 5, 2026
- Market cap
- $3.63M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2124 (−77.97%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Cannaisseur Group Inc. saw revenue fall 100.0% to $0 over the twelve months to Jun 30, 2026.
Revenue
$0
-100.0% vs. a year earlier
Operating income
-$988.97K
TTM Q2 2026
EPS, diluted
-$0.01
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.63M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $0
- Net income
- -$1.04M
- EPS, diluted
- -$0.01
- Diluted shares
- 60M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
$0-100.0% YoY
Gross profit
-$582
Operating income
-$988.97K
Net income
-$1.04M
EPS, diluted
-$0.01
Reported periodTrailing twelve months